Public Health

Dr. Moran

Bodas

Resilience in a pandemic

Dr. Bodas deciphers the psychosocial determinants of preparedness behavior and develop newer and more refined behavioral models that could explain why disaster risk communication falls short of achieving its goal of promoting public readiness to emergencies . At the Gertner Institute, his research focuses on the epidemiology of injury. The Israeli National Trauma Registry provides 25 years of data covering hospitalized cases due to traumatic injuries in Israel. This vast database allows clinical aspects of treatment provided to casualties, as well as the impact of interventions and public health policies designed for the trauma system . These studies have supported the improvement of the Israeli trauma system, which is now one of the leading trauma systems in the world .

Dr. Bodas , MPH, PhD, is a member of the Department of Emergency Management and Disaster Medicine in the School of Public Health. He is also the acting director of the Israel National Center for Trauma & Emergency Medicine Research, Gertner Institute of Epidemiology. Dr. Bodas holds a B.Sc. in Life Sciences, a Master’s in Public Health (MPH) with an emphasis in emergency and disaster management, and a PhD in Disaster Management, all from Tel Aviv University. He completed a post-doctoral fellowship at the Research Center in Emergency and Disaster Medicine (CRIMEDIM) in Novara, Italy, where he studied the Italian population's preparedness for earthquakes. He is an affiliated faculty member at the PhD Program in Global Health, Humanitarian Aid and Disaster Medicine and the European Master in Disaster Medicine, both at Università del Piemonte Orientale, Italy.

Public Health

Prof. Gabriel Chodick

Epidemiology and database research

The integrated system of state -mandated health providers in Israel has facilitated the linking of inpatient, outpatient, hospital, ambulatory care, pharmaceutical, and laboratory data . Prof. Chodick uses the wealth of real-world data for policymaking and guidelines to increase well-being and improve prevention efforts . His focus has been to study the use of new drugs, study the long -term adverse outcomes of cancer, metabolic disorders, and vascular events, and assess the economic and medical burden of diseases . During the pandemic,

Prof. Gabriel Chodick , PhD, MHA, recently joined as on -campus faculty of the School of Public Health , after heading the Maccabitech Institute for Epidemiology and Database Research at Maccabi Healthcare Services, the second largest HMO in Israel . He earned M . Sc . and Ph . D. degrees in Epidemiology from Tel Aviv University, where he also completed his Master’s in Health Administration . He was a Fulbright Visiting Scholar at the School of Public Health, UNC at Chapel Hill and completed a twoyear post-doctoral fellowship at the National Cancer Institute in Bethesda . Prof. Chodick has authored or co -authored over 350 articles in peer-reviewed journals, primarily in the area of pharmacoepidemiology and big data analytics . His major areas of interest include outcome research using real -world data, drug adherence, vaccine effectiveness, and preventive medicine .

Prof. Chodick has led observational studies that have given immediate findings to decision makers such as the safety of ACE -I therapy, and the effectiveness of COVID vaccines and anti-viral therapies. Chodick’s lab’s goal is to further develop the use of healthcare electronic records, registries, and other data resources to improve the quality of healthcare delivery and clinical innovation .

TAU Faculty of Medicine